COXG heads into its July 28 results with a striking contradiction — the founder has been a heavy net buyer, yet the stock has dropped 5% in a week and costs more than 36% annually to borrow.
The founder and Executive Chairman, Enrique José Riquelme Vives, purchased 2.4 million shares at €14.30 in late May — a transaction worth roughly $40 million. That single purchase accounts for the bulk of a net insider buying position of around $45 million over the past 90 days. At the same time, the same individual sold smaller parcels in late May and mid-June, creating a mixed but overall bullish picture from the controlling shareholder, who holds nearly 58% of the company through Inversiones Riquelme Vives. The CFO also added shares in June, stepping in alongside the founder. Against that backdrop, the stock has drifted the wrong way — closing at €11.20 on July 24, well below the €14.30 price at which the Chairman put $40 million to work.
The borrow market captures that tension precisely. Borrowing shares costs over 36% per year — a level that has been elevated all year, peaking above 46% in late May before easing slightly. Yet actual short positioning is negligible. Borrow availability is effectively uncapped, with nearly 2 million shares available relative to a tiny borrowed pool. The lending market is expensive not because shorts are crowding in, but because the stock is genuinely hard to borrow structurally — a Spanish small-cap with a tightly held register. The ORTEX short score of 38.8 sits in the lower-middle of its range, consistent with limited short conviction rather than an aggressive bearish bet.
The bull and bear cases hinge largely on valuation and earnings delivery. On valuation, the numbers are arresting: a P/E of 6.8x and an EV/EBITDA of under 2x place the stock in the cheapest tier of renewable infrastructure names in Europe, and the EV/EBIT factor ranks in the 89th percentile of the broader universe. Forward earnings revisions have been sharply positive, with consensus pointing to triple-digit EPS growth year-on-year. The two analysts covering the stock hold a consensus "hold" rating, with a mean price target of €15.10 — roughly 35% above the current price — though that consensus was last updated in late June and should be treated as a snapshot rather than a live view. Bears will focus on the stock's underperformance: COXG has lagged Spanish mid-cap peers and sits materially below the price at which its own chairman was willing to buy in bulk. The fact that the stock has continued to slide despite that signal leaves the market asking whether there is something the buyers are seeing that the price has not yet confirmed.
The July 28 print is therefore less a test of the growth narrative — which the numbers support — and more a test of whether the company can provide enough operational clarity to close the gap between a €11.20 market price and the valuation its own insiders and analysts believe it deserves.
See the live data behind this article on ORTEX.
Open COXG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
